Buscar en
Vacunas (English Edition)
Toda la web
Inicio Vacunas (English Edition) Most often read
Journal Information

Most often read

183
The status of COVID-19 vaccines in India: A review
Deepak Kumar Jha, Kumar Pranay, Samiksha, Amit Kumar, Niti Yashvardhini
Vacunas. 2023;24:218-47
183
111
Autoimmune diseases related to post-SARS-CoV-2 vaccination: A rheumatology perspective
Farhad Dadgar, Jorge Casseb, Masoud Keikha
Vacunas. 2023;24:400-1
111
103
Adverse events following COVID-19 vaccination among pregnant women attending primary health centers: An active-surveillance study
Narayana Goruntla, Basappa Karisetty, Nandini Nandini, Bharadwaj Bhupasamudram, Himaja Reddy Gangireddy, Kasturi Vishwanathasetty Veerabhadrappa, Joseph Obiezu Chukwujekwu Ezeonwumelu, Vishnuvandana Bandaru
Vacunas. 2023;24:291-7
103
101
Autumn 2023 SARS-CoV-2 immunization: Who should be vaccinated and how?
Fernando Moraga-Llop, Magda Campins-Martí
Vacunas. 2023;24:261-5
101
91
COVID vaccine: Social, menstrual and psychological aftermath
Swati Gupta, Divya Rai, Shipra Shukla
Vacunas. 2023;24:326-34
91
64
Immuno-informatics design of a multimeric epitope peptide-based vaccine against dengue virus serotype-2
Mohamed Sheik Tharik Abdul Azeeze, Rajaguru Arivuselvam
Vacunas. 2023;24:380-93
64
47
Impact of vaccination on the entire population and dose-response relation of COVID-19
Abdul Malek, Ashabul Hoque
Vacunas. 2023;24:278-90
47
46
The polymorphisms of TNF-α related-gene and antibody production following third dose of COVID-19 vaccination: A pilot study
Phey Liana, Zen Hafy, Soilia Fertilita, Ella Amalia, Veny Larasati, Tungki Pratama Umar
Vacunas. 2023;24:273-7
46
25
Multivalent vaccines against new SARS-CoV-2 hybrid variants
Kiarash Ghazvini, Masoud Keikha
Vacunas. 2023;24:76-7
25
21
The significant role of Carbapenems-resistant Acinetobacter Baumannii in mortality rate of patients with COVID-19
Ali AliMohammadi, Nahid Chezani-sharahi, Zahra Asgari Hezaveh, Elnaz Abbasi, Aref Shariati, Ehsanollah Ghaznavi-Rad
Vacunas. 2023;24:13-8
21
21
Epidemiological study of vaccination against SARS-CoV-2 and its impact on COVID-19 progression in a cohort of patients in gran Canaria
Alejandro de Arriba Fernández, José Luis Alonso Bilbao, Alberto Espiñeira Francés, Antonio Cabeza Mora, Ángela Gutiérrez Pérez, Miguel Ángel Díaz Barreiros
Vacunas. 2023;24:308-16
21
16
An immunoinformatics approach to study the epitopes of SARS-CoV-2 helicase, Nsp13
Sushant Kumar, Khushboo Kumari, Gajendra Kumar Azad
Vacunas. 2023;24:190-202
16
15
Immunizing adult respiratory patients, shall we dance along?
Felipe Villar-Álvarez, David de la Rosa-Carrillo, Fernando Fariñas-Guerrero
Vacunas. 2023;24:161-3
15
12
Associated factors in the intention of vaccination against COVID-19, in Popayán, Cauca Colombia
Omar Andrés Ramos Valencia, Yuliana Buitrón Gonzalez, Jorge Sotelo Daza, Andrés Felipe Villaquiran
Vacunas. 2023;24:174-81
12
10
Evaluating the characteristics of patients with SARS-CoV-2 infection admitted during COVID-19 peaks: A single-center study
Seyede Faezeh Mousavi, Mohammadamin Ebrahimi, Seyed Amirhosein Ahmadpour Moghaddam, Narges Moafi, Mahbobe Jafari, Ayoub Tavakolian, Mohsen Heidary
Vacunas. 2023;24:27-36
10
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos